Literature DB >> 1596895

Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer.

M Tanaka1, H Sasaki, I Kino, T Sugimura, M Terada.   

Abstract

Eight complementary DNA (cDNA) clones highly expressed in fetal rat stomach but not in normal adult rat stomach were isolated after screening 2 x 10(4) independent recombinants from a subtracted cDNA library. The cDNA library was first prepared from RNAs of total stomach at 16 days gestational period, and this cDNA library was subtracted by cDNAs prepared from adult rat total stomach RNA, using a novel PCR-based cDNA subtraction method. Northern blot analysis revealed that as many as six of eight clones thus isolated were overexpressed in at least some of the human or rat gastric cancers. From analysis of partial nucleotide sequence, four cDNA clones were identified as profilin, pro-alpha 1 (1) collagen, nucleolar protein B23.2, and elongation factor 1 alpha subunit. The remaining two clones were derived from novel genes. These novel genes, L-1 and L-2, are developmentally well regulated in the stomach. The present results clearly show that genes expressed preferentially in embryo stomach are most likely to be highly expressed in gastric cancer. The method described here provides us with a rapid method for identification of genes with significantly increased expression in cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596895

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.

Authors:  June Li; Daniel P Sejas; Sandeep Burma; David J Chen; Qishen Pang
Journal:  Carcinogenesis       Date:  2007-02-02       Impact factor: 4.944

Review 2.  Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

Authors:  Rachel Rau; Patrick Brown
Journal:  Hematol Oncol       Date:  2009-12       Impact factor: 5.271

3.  Computer-assisted stereological analysis of gastric volume during the human embryonic period.

Authors:  E Macarulla-Sanz; J Nebot-Cegarra; F Reina-de la Torre
Journal:  J Anat       Date:  1996-04       Impact factor: 2.610

Review 4.  Structure and functions of profilins.

Authors:  Kannan Krishnan; Pierre D J Moens
Journal:  Biophys Rev       Date:  2009-06-04

5.  Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.

Authors:  Ya-Jun Cheng; Zhen-Xin Zhu; Jian-Sheng Zhou; Zun-Qi Hu; Jian-Peng Zhang; Qing-Ping Cai; Liang-Hua Wang
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

6.  p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.

Authors:  Sriram Venneti; Paul Le; Daniel Martinez; Katherine W Eaton; Nikhil Shyam; Kelly L Jordan-Sciutto; Bruce Pawel; Jaclyn A Biegel; Alexander R Judkins
Journal:  J Neuropathol Exp Neurol       Date:  2011-07       Impact factor: 3.685

7.  Prognostic significance of the co-expression of nucleophosmin and trefoil factor 3 in postoperative gastric cancer patients.

Authors:  Yong Li; Zhenqing Sun; Kewei Liu; Wensheng Qiu; Ruyong Yao; Tongtong Feng; Chao Xin; Lu Yue
Journal:  Mol Clin Oncol       Date:  2014-07-17

8.  TAT-mediated intracellular delivery of NPM-derived peptide induces apoptosis in leukemic cells and suppresses leukemogenesis in mice.

Authors:  Yun Zhou; Wei Du; Tara Koretsky; Grover C Bagby; Qishen Pang
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

9.  Developmental expression of the neurotensin gene in the rat liver.

Authors:  B M Evers; S Rajaraman; D H Chung; C M Townsend; X Wang; K Graves; J C Thompson
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

10.  Chromosomal losses are associated with hypomethylation of the gene-control regions in the stomach with a low number of active genes.

Authors:  Yu-Chae Jung; Seung-Jin Hong; Young-Ho Kim; Sung-Ja Kim; Seok-Jin Kang; Sang-Wook Choi; Mun-Gan Rhyu
Journal:  J Korean Med Sci       Date:  2008-12-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.